240 related articles for article (PubMed ID: 32858245)
1. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy.
Palmieri M; Di Sarno L; Tommasi A; Currò A; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Fallerini C; Arzini A; Pinto A; Vaghi M; Renieri A
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):740-744. PubMed ID: 32858245
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.
Palmieri M; Pinto AM; di Blasio L; Currò A; Monica V; Sarno LD; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Mussolin B; Fallerini C; Molinaro F; Vaghi M; Renieri A; Primo L
Vascular; 2021 Feb; 29(1):85-91. PubMed ID: 32588787
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation.
Palmieri M; Currò A; Tommasi A; Di Sarno L; Doddato G; Baldassarri M; Frullanti E; Giliberti AR; Fallerini C; Spinazzola A; Pinto AM; Renieri A; Vaghi M
JVS Vasc Sci; 2020; 1():176-180. PubMed ID: 34617046
[TBL] [Abstract][Full Text] [Related]
4. Genetic tests in lymphatic vascular malformations and lymphedema.
Michelini S; Paolacci S; Manara E; Eretta C; Mattassi R; Lee BB; Bertelli M
J Med Genet; 2018 Apr; 55(4):222-232. PubMed ID: 29440349
[TBL] [Abstract][Full Text] [Related]
5. Construction of a reference material panel for detecting
Xu J; Qu S; Sun N; Zhang W; Zhang J; Song Q; Lin M; Gao W; Zheng Q; Han M; Na C; Xu R; Chang X; Yang X; Huang J
J Clin Pathol; 2021 May; 74(5):314-320. PubMed ID: 32817175
[TBL] [Abstract][Full Text] [Related]
6. RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.
Macmurdo CF; Wooderchak-Donahue W; Bayrak-Toydemir P; Le J; Wallenstein MB; Milla C; Teng JM; Bernstein JA; Stevenson DA
Am J Med Genet A; 2016 Jun; 170(6):1450-4. PubMed ID: 26969842
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases.
Ten Broek RW; Eijkelenboom A; van der Vleuten CJM; Kamping EJ; Kets M; Verhoeven BH; Grünberg K; Schultze Kool LJ; Tops BBJ; Ligtenberg MJL; Flucke U
Genes Chromosomes Cancer; 2019 Aug; 58(8):541-550. PubMed ID: 30677207
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
Luks VL; Kamitaki N; Vivero MP; Uller W; Rab R; Bovée JV; Rialon KL; Guevara CJ; Alomari AI; Greene AK; Fishman SJ; Kozakewich HP; Maclellan RA; Mulliken JB; Rahbar R; Spencer SA; Trenor CC; Upton J; Zurakowski D; Perkins JA; Kirsh A; Bennett JT; Dobyns WB; Kurek KC; Warman ML; McCarroll SA; Murillo R
J Pediatr; 2015 Apr; 166(4):1048-54.e1-5. PubMed ID: 25681199
[TBL] [Abstract][Full Text] [Related]
9. Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.
Greene AK; Goss JA
Plast Reconstr Surg; 2018 May; 141(5):709e-717e. PubMed ID: 29697621
[TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
Bennett CW; Berchem G; Kim YJ; El-Khoury V
Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
[TBL] [Abstract][Full Text] [Related]
11. Somatic Activating PIK3CA Mutations Cause Venous Malformation.
Limaye N; Kangas J; Mendola A; Godfraind C; Schlögel MJ; Helaers R; Eklund L; Boon LM; Vikkula M
Am J Hum Genet; 2015 Dec; 97(6):914-21. PubMed ID: 26637981
[TBL] [Abstract][Full Text] [Related]
12. Variant discovery in patients with Mendelian vascular anomalies by next-generation sequencing and their use in patient clinical management.
Mattassi R; Manara E; Colombo PG; Manara S; Porcella A; Bruno G; Bruson A; Bertelli M
J Vasc Surg; 2018 Mar; 67(3):922-932.e11. PubMed ID: 28655553
[TBL] [Abstract][Full Text] [Related]
13. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.
Ye C; Pan L; Huang Y; Ye R; Han A; Li S; Li X; Wang S
J Vasc Surg; 2011 Dec; 54(6):1760-8. PubMed ID: 21962923
[TBL] [Abstract][Full Text] [Related]
15. Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations.
Zenner K; Jensen DM; Cook TT; Dmyterko V; Bly RA; Ganti S; Mirzaa GM; Dobyns WB; Perkins JA; Bennett JT
Genet Med; 2021 Jan; 23(1):123-130. PubMed ID: 32884133
[TBL] [Abstract][Full Text] [Related]
16. Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy.
Serio VB; Palmieri M; Loberti L; Granata S; Fallerini C; Vaghi M; Renieri A; Pinto AM
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807022
[TBL] [Abstract][Full Text] [Related]
17. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
[TBL] [Abstract][Full Text] [Related]
18. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
[TBL] [Abstract][Full Text] [Related]
19. Genetic Screening in a Large Cohort of Italian Patients Affected by Primary Lymphedema Using a Next Generation Sequencing (NGS) Approach.
Michelini S; Vettori A; Maltese PE; Cardone M; Bruson A; Fiorentino A; Cappellino F; Sainato V; Guerri G; Marceddu G; Tezzele S; Bertelli M
Lymphology; 2016 Jun; 49(2):57-72. PubMed ID: 29906362
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
